Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

(2015) William E. Klunk et al.   Alzheimers & Dementia

Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging

(2015) Konstantinos Chiotis et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease

(2015) Yiling Xiao et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease

(2015) Yiling Xiao et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density

(2015) Craig Curtis et al.   JAMA Neurology

Amyloid-β, Anxiety, and Cognitive Decline in Preclinical Alzheimer Disease

(2015) Robert H. Pietrzak et al.   JAMA Psychiatry

[18F]FLUTEMETAMOL AMYLOID PET IN SYMPTOMATIC ALZHEIMER'S DISEASE (AD) AND PATHOLOGICALLY PRECLINICAL AD (P-PREAD) IN COMPARISON TO NON-AD CONTROLS: IMPACT OF CEREBRAL AMYLOID ANGIOPATHY

(2014) Dietmar Thal et al.   Alzheimers & Dementia

DIAGNOSTIC VALUE OF AMYLOID IMAGING IN EARLY ONSET DEMENTIA

(2014) Marissa Deborah Zwan et al.   Alzheimers & Dementia

[18F]FLUTEMETAMOL AMYLOID PET IMAGING: OUTCOME OF A PHASE III STUDY IN SUBJECTS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT AFTER A 3-YEAR FOLLOW-UP

(2014) David A. Wolk et al.   Alzheimers & Dementia

Is 18F-Flutemetamol PET/CT Able to Reveal Cardiac Amyloidosis?

(2014) Renaud Lhommel et al.   CLINICAL NUCLEAR MEDICINE

PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB

(2014) Daniele de Paula Faria et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

(2014) S. M. Landau et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Reduced retention of Pittsburgh compound B in white matter lesions

(2014) Lidia Glodzik et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads

(2014) L. Thurfjell et al.   JOURNAL OF NUCLEAR MEDICINE

Diagnostic value of [18F]flutemetamol amyloid PET: comparison between imaging and neuropathology

(2014) Dietmar R. Thal et al.   NEUROBIOLOGY OF AGING

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42

(2014) Sebastian Palmqvist et al.   JAMA Neurology

Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease

(2014) Ronald Lautner et al.   JAMA Psychiatry

Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury

(2014) E M Mitsis et al.   Translational Psychiatry

In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol

(2014) Anniina Snellman et al.   EJNMMI Research

Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus

(2014) Ville Leinonen et al.   Acta Neuropathologica Communications

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Amyloid Deposition and Cognition in Older Adults: The Effects of Premorbid Intellect

(2013) K. Duff et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

Detection of brain amyloid β deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B

(2013) Nobuyuki Kawai et al.   BRAIN INJURY

Positron emission tomography with [18F]flutemetamol and [11C]PiB forin vivodetection of cerebral cortical amyloid in normal pressure hydrocephalus patients

(2013) V. Leinonen et al.   EUROPEAN JOURNAL OF NEUROLOGY

[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease

(2013) Shizuo Hatashita et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Positron emission tomography radioligands forin vivoimaging of Aβplaques

(2013) N. Scott Mason et al.   JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data

(2013) R. Lundqvist et al.   JOURNAL OF NUCLEAR MEDICINE

Microglia, Amyloid and Glucose Metabolism in Parkinson’s Disease with and without Dementia

(2013) Paul Edison et al.   NEUROPSYCHOPHARMACOLOGY

Amyloid Imaging With Carbon 11–Labeled Pittsburgh Compound B for Traumatic Brain Injury

(2013) Young T. Hong et al.   JAMA Neurology

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers

(2013) Katarzyna Adamczuk et al.   NeuroImage-Clinical

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

(2012) Juha O. Rinne et al.   ACTA NEUROPATHOLOGICA

Flutemetamol F 18 injection PET images reflect brain beta-amyloid levels

(2012) Chris Buckley et al.   Alzheimers & Dementia

Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease

(2012) Ranjan Duara et al.   Alzheimers & Dementia

The spectrum of disease in chronic traumatic encephalopathy

(2012) Ann C. McKee et al.   BRAIN

Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease

(2012) Anniina Snellman et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease

(2012) Victor L. Villemagne et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

(2012) David A Wolk et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET

(2012) G. Antoni et al.   JOURNAL OF NUCLEAR MEDICINE

Amyloid-  Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

(2012) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients

(2012) Dean F. Wong et al.   MOLECULAR IMAGING AND BIOLOGY

Brain amyloid and cognition in Lewy body diseases

(2012) Stephen N. Gomperts et al.   MOVEMENT DISORDERS

Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment

(2012) Lennart Thurfjell et al.   Neurodegenerative Diseases

Binary classification of 18F-flutemetamol PET using machine learning: Comparison with visual reads and structural MRI

(2012) Rik Vandenberghe et al.   NEUROIMAGE

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents

(2012) Chester A. Mathis et al.   SEMINARS IN NUCLEAR MEDICINE

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

(2011) Victor L. Villemagne et al.   ANNALS OF NEUROLOGY

Association Between In Vivo Fluorine 18–Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology

(2011) David A. Wolk   ARCHIVES OF NEUROLOGY

Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias

(2011) V. L. Villemagne et al.   JOURNAL OF NUCLEAR MEDICINE

Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study

(2011) J. Koivunen et al.   NEUROLOGY

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications

(2011) Robert Laforce et al.   Alzheimers Research & Therapy

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology

(2010) Roy Hamilton et al.   ANNALS OF NEUROLOGY

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

(2010) Ville Leinonen et al.   ANNALS OF NEUROLOGY

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

(2010) Rik Vandenberghe et al.   ANNALS OF NEUROLOGY

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4′-methylaminophenyl)- 6-hydroxybenzothiazole

(2010) Bruno Stankoff et al.   ANNALS OF NEUROLOGY

Pons as an alternative reference region in [18F]flutemetamol quantification of amyloidosis

(2010) Kerstin Heurling et al.   NEUROIMAGE

Amyloid imaging in mild cognitive impairment subtypes

(2009) David A. Wolk et al.   ANNALS OF NEUROLOGY

Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging

(2009) M. Koole et al.   JOURNAL OF NUCLEAR MEDICINE

Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias

(2009) M. T. Fodero-Tavoletti et al.   JOURNAL OF NUCLEAR MEDICINE

Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

(2009) N. Nelissen et al.   JOURNAL OF NUCLEAR MEDICINE

Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study

(2009) A. Okello et al.   NEUROLOGY

Comparison of the binding of 3′-F-PiB and PiB in human brain homogenates

(2008) Chester A. Mathis et al.   NEUROIMAGE

PET imaging of amyloid deposition in patients with mild cognitive impairment

(2007) Anton Forsberg et al.   NEUROBIOLOGY OF AGING